EXEveline Xavier-Souza

Eveline Xavier-Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eveline Xavier-Souza has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Knowledge on post-exposure prophylaxis, sexual behavior, and vulnerabilities to HIV and other STIs among young adults in Brazil

    by Vinicius Nascimento dos Santos, Eveline Xavier Pereira de Souza, Maiara Santos Timbó, Ana Gabriela Alvares Travassos

    Introduction: Post-exposure prophylaxis (PEP) is the use of antiretroviral drugs (ARVs) to reduce the risk of human immunodeficiency virus (HIV) infection after potential risk exposure. ARV-based interventions are recommended as part of combination HIV prevention, especially for key populations. Objective: The aim of this study was to measure knowledge about PEP among university students. Methods: A cross-sectional study was conducted on university students from the Health, Education, Exact, and Human Sciences Departments of the State University of Bahia, Brazil. Sociodemographic data, information on sexual behavior, and knowledge of PEP were collected through a standardized self-applied questionnaire. Results: We analyzed 1580 questionnaires, of which 66.7% (1024/1536) were from females, with a mean age of 23.9 (±6.5) years, and 35.4% (448/1264) reported irregular use of condoms and regular use was not associated with being students from the health area (p=0.44, OR 0.90, 95%CI 0.69–1.17). Regarding PEP, 28.5% (449/1578) had known about it and their knowledge was statistically associated with men who have sex with men (MSM) (p<0.01, OR 3.92, 95%CI 2.45–6.28). It was noted that 94.0% (1485/1579) did not know the time limit for starting PEP, 95.1% (1500/1578) did not know the duration of prophylaxis, and 91.1% (1437/1577) did not know where to get PEP. Finally, 0.4% (7/1578) referred to previous use and 96.6% (1488/1540) would not change their sexual behavior after knowing about PEP. Conclusion: PEP is a prevention strategy available for decades and is safe, effective, and cost-effective. However, it is underutilized and a lack of knowledge on PEP is one of the main obstacles to access. Among university students, there is a limited knowledge about PEP acting as a barrier in preventing new infections, which shows the need for interventions based on sexual-health education, stimulating the reduction of risk behaviors and disseminating information about combination prevention.


  • Open Access

    Prevalence of ureaplasma urealyticum, mycoplasma hominis and human papillomavirus coinfection in people attending a sexually transmitted infections (STI)/HIV reference centre in Salvador, Bahia, Brazil

    by Alyce Lima Amorim, Ana Gabriela Álvares Travassos, Geovane Cruz de Souza, Vitor Cunha Fontes, Maiara Timbó, Eveline Xavier Souza

    Introduction: Ureaplasma urealyticum and Mycoplasma hominis are frequently found at many women’s and men’s urogenital tract, and have been associated with non-gonococcal urethritis, cervicitis, infertility, chorioaminionitis and adverse pregnancy outcomes. Some studies show high prevalence of human papillomavirus (HPV) in patients with non-gonococcal urethritis, while also presenting high frequency of Ureaplasma urealyticum infection in women with cervicalcytology abnormalities and men with genital warts. Objectives: To evaluate the prevalence of Ureaplasma urealyticum, Mycoplasma hominis and HPV coinfection in people attending a sexually transmitted infections (STI)/HIV reference centre and to identify the risk factors associated. Methods: A cross-sectional study with patients aged >18 years, carried out for Ureaplasma urealyticum and Mycoplasma hominis from July 1st to December 31, 2015, in a STI/HIV reference centre from the State of Bahia, Brazil. Sociodemographic and clinical data were obtained from secondary data from patients’ charts and laboratory findings, and analyzed using SPSS 20.0. Pearson’s χ2 test or Fisher’s exact test was used to evaluate categorical variables. HPV clinical diagnosis was considered positive as the presence of genital warts. Results: In this study, 849 patients were included — 196 men and 653 women. Of the sample, 51.4% was diagnosed with at least one of the two bacteria. The prevalence of Mycoplasma hominis infection was higher in coinfection (16.7%) than in isolated infection (2.2%). The prevalence of Ureaplasma urealyticum isolated infection was 32.4%. A strong association was found between the presence of genital warts and Ureaplasma urealyticum infection, with an estimated risk of 1.230 (p=0.014). Conclusion: Our findings suggest the need for further investigation for Ureaplasma urealyticum infection in patients presenting genital warts on physical examination. In addition, in this context, greater attention should be given to women and pregnant women.


  • P3.75 Viral suppression in late presenting hiv-infected pregnant women

    by E Xavier-Souza, I Nóbrega, Timbó, C Barone, S Fernandes, E Netto, Ag Travassos

    Introduction The maternal HIV viral load (VL) is a major predictor of mother to child transmission (MTCT). Therefore, it is necessary a rapid decrease of VL among late-presenting (LP) (after 28 weeks) pregnant women living with HIV (PWLH) aiming viral suppression (VS). We aimed to identify the population of LP-PWLH and compare the VS to the group who had earlier access (EA) to prenatal care. Methods A retrospective cohort carried out at the major HIV reference centre in Bahia, Brazil. Medical records of PWLH attended at prenatal care were reviewed from January 2011 to December 2013. HIV VL and TCD4+ count data were obtained from the national database. Statistical analyses were performed with SPSS 20.0. Results A total of 235 PWLH enrolled in the study, of which 29.4% were LP. Among the latter, the mean age was 28.3 (±6.9) years, similar to the EA group. Thirty four percent of the LP had 10 3.4; p10 3.8; p=0.02). LP were more likely to not have a second VL during pregnancy or early peripartum (33.3%; pvs 71.8%; pConclusion LP showed an increased risk of MTCT, with recent HIV diagnosis, higher VL at prenatal onset and a lower rate of VS. Thus, the use of integrase inhibitors would be a better choice for this population, since it promotes a quickly decrease of VL.

  • P3.124 Adolescents living with hiv/aids – different approaches in different modes of hiv transmission

    by Krysna Pires, Eveline Xavier-Souza, Maiara Timbó, Raiza Trindade, Camila Souza, Ana Gabriela Travassos

    Introduction Recently, the number of adolescents infected with HIV has been increasing worldwide, but there is still little information available on the characteristics of this population. The aim of this study is to compare the characteristics of adolescents living with HIV attending a Sexually Transmitted Infection (STI) Referral Centre according to the modes of transmission. Methods A cross-sectional study evaluating adolescents between 10 and 19 years of age, carried out from January to August 2012, at the state STI reference centre in Bahia, Brazil. Sociodemographic and clinical data were obtained by reviewing charts and analysed through SPSS 20.0. Results A total of 123 adolescents living with HIV were attended during the study period, 76.3% (90/118) of them acquired the virus through vertical transmission (VT), whereas 22.9% (27/118) acquired via sexual transmission (ST). Regarding the adolescents with VT, the group was younger than the ST, with 93.7%Conclusion We observed two distinct groups, defined according to the modes of transmission, both showing specific characteristics. Thus, is it evident the need of customise the health care and promotion according to each group.

  • P3.185 Adolescents with hpv: the profile of young people attending a sti and hiv reference centre in salvador/bahia

    by Raiza Trindade, Eveline Xavier-Souza, Maiara Timbó, Krysna Lessa, Camila Souza, Ana Gabriela Travassos

    Introduction The adolescence is a period marked by intense vulnerability, with a high prevalence of HPV, mostly of transient infections. We aimed to identify the population of adolescents infected with HPV and risk factors associated. Methods A cross-sectional study evaluating adolescents (from 10 to 19 years of age) carried out from January to August 2012 at the major Sexually Transmitted Infections (STI) Reference Centre in Bahia, Brazil. Sociodemographic and clinical data were obtained by reviewing charts and analysed through SPSS 20.0. Results Of the adolescents evaluated, 324 had the diagnosis of HPV, evidencing an HPV prevalence of 62.5%. Among those, the mean age was 16.8 (±1.5) years and the sexual debut occurred at 13.2 (±3.5) years of age. There was an association between the female gender and the diagnosis of HPV (p=0.02; OR 2.69, 95% CI 1.10–6.58). There was 91.9% (295/321) of clinical diagnosis of HPV, and 61.9% (199/321) of genital warts among the infected population. 90.9% (280/308) of the infected adolescents underwent treatment for HPV. Conclusion The clinical and epidemiological profile of these adolescents revealed the need for prevention campaigns against STIs with accessible language, promoting access to information. Access to HPV vaccine is now possible, and it is still necessary to stimulate follow-up and treatment in order to reduce this infection and its associated diseases.


  • Open Access

    P3.32 Adolescents infected by syphilis – a retrospective cohort in a reference service

    by Souza Cs, Xavier-Souza E, Lessa Kp, Trindade R, Timbó, Ag Travassos

    Introduction Syphilis persists as a major and ascendant health issue. However, the impact of this disease during the adolescence, a period of behavioural, sexual and psychologic vulnerabilities, is still underexplored. We aimed to evaluate the follow-up of syphilis infected adolescents attended at a reference service of sexually transmitted infections (STI). Methods A retrospective cohort study using data from medical records of adolescents (10 to 19 years old) with diagnosis of syphilis attended at the states STI reference centre, from January to August 2012. Results Among 776 adolescents attending the service, 58 had a diagnosis of syphilis (7.47%). The majority was male (51.7%), mean age was 16.8 (±1.35) years, 92.3% attended school, and 58.1% had ≤8 years of schooling; 39.4% referred drinking alcohol and 39.5% drug use. Among the adolescents, 98.3% had already initiated sexual life, with the mean age of sexual debut of 14.2 (±1.48) years, with an average of 2.33 (±2.55) lifetime sexual partners. About 14.0% declared to be homosexual, 85.4% referred irregular condom use, 22.2% of the girls were pregnant, with mean age at first gestation of 16.0 (±1.09) years. A parcel of 4.8% of the adolescents were HIV-infected, 31.0% reported a previous STI (p=0.02, OR 2.68, 95% CI 1.16–6.17), and 52.3% had another current STI. The mean number of medical visits was 2.33, 22.8% had primary syphilis, 17.5% had the secondary phase of the disease and 59.6% had latent or late syphilis. The social and demographic variables were not statistically different among the adolescents in the different stages of syphilis. The genital ulcer complaint was related to the diagnosis of primary or secondary syphilis (p=0.01, OR 8.53, 95% CI 1.61–45.1). 91.4% of adolescents received treatment for syphilis and 56.6% performed a cure control. Conclusion The high prevalence of other STIs associated with syphilis in adolescents demonstrates the limited knowledge of this population to care and prevention strategies, and remains a challenge for specialised services in the diagnosis and treatment of STI/HIV.

  • P3.83 Antimicrobial resistance ofureaplasma urealyticumandmycoplasma hominisresearched at a reference centre in salvador, bahia

    by Gc Souza, E Xavier-Souza, Timbó, V Cunha, Ag Travassos

    Introduction: Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) are potentially pathogenic organisms commonly found in the urogenital tract, with colonisation rates up to 80% and 40% worldwide, respectively. The aim of this study was to estimate antimicrobial resistance by UU and MH, and identify the antimicrobial agents involved in bacterial resistance. Methods A cross-sectional study, with data obtained retrospectively through medical records review. We analysed 140 patients whose women’s endocervical samples and men’s urine tested positive for MH and UU. The test used for the diagnosis and evaluation of antimicrobial resistance was the MYCOFAST Screening EvolutioN 3 kit. Results The majority of patients were female (90.7%), 57.9% of the patients had >29 years of age and 84.3% did not have a stable union. About 70.0% of the patients tested positive for UU, 3.0% for MH, and 27.0% for both. HIV co-infection was seen in 32.1% and HPV in 30.0%. Absence of current history of Chlamydia trachomatis was a protective factor for the acquisition of azithromycin resistance (p=0.04). As for the antimicrobials, doxycycline showed sensitivity rates higher than 96% for both infections, while azithromycin showed 86.8% of sensitivity for UU, but resistance of 75% for MH. Ciprofloxacin showed sensitivity rates lower than 15% for both infections, while less than 35% were strains sensible to ofloxacin. Erythromycin resistance rates ranged over 65% for the UU-MH coinfection, while over 90% of sample was sensible to tetracycline and clarithromycin resistance rates ranged from 7.1% for UU to 100% for MH. Conclusion The use of ciprofloxacin and ofloxacin is highly debatable considering the high rates of total and intermediate resistance. In our population, doxycycline showed high efficiency and is therefore recommended for the treatment of UU and MH infections. Monitoring antimicrobial resistance is ?fundamental for the adequacy of the therapeutic recommendations.

  • P3.10 Hpv clearance in a brazilian women living with hiv cohort

    by Aga Travassos, Em Netto, E Xavier-Souza, Ip Nóbrega, Ksag Brandão, Pma Silva, Sa Fernandes, K Abbehusen, M Timbó, T Haguihara, et al.

    Introduction Persistent infection with high-risk human papillomavirus (HR-HPV) is necessary for the development of precursor lesions and cervical cancer. HPV infection among women living with HIV/AIDS (WLHA) occurs more frequently, presents a higher parcel of persistent infections and an earlier progression to cancer. We aimed to evaluate the HR-HPV infection and clearance, and its association with HIV viral suppression, immunological response, and other risk factors among WLHA followed in a STD/HIV reference centre. Methods This is a cohort study conducted at a reference centre for STD/AIDS in Northeastern Brazil from September 2013 to September 2015. Follow-up visits were conducted at 6 and 12 months from enrolment, where socio-epidemiological data was obtained through standardised form. Cervical samples were collected for conventional cytology and HPV DNA research (PCR COBAS Roche) in addition to blood samples for TCD4+ lymphocyte count and HIV viral load. Results We prospectively evaluated 333 women. HR-HPV DNA prevalence was 39.6% during the follow-up. HPV-16 was present in 6.0%, HPV-18 in 5.4% and 37.8% WLHA had other HR-HPV (31,33,35,39,45,51,52,56,58,59,66 and 68). The HR-HPV incidence was 10.6% in 6 months visit and 6.5% in 12 months visit. Variables associated with HR-HPV incidence were: age ≤30 years, combined oral contraceptive use, smoking and detectable HIV viral load. The HR-HPV clearance was 31.7% and was associated with age >30 years and lymphocytes count >350 cels/mm3 at enrolment. Nulliparous women had higher HR-HPV clearance rates. Conclusion These findings have contributed to the knowledge about the group of women that need a more careful HPV screening, while described the association of efficient immunological response and HIV viral suppression with a lower HR-HPV incidence and increased clearance of HPV-HR.

  • P4.107 Hiv post-exposure prophylaxis: perception of young students from a university of bahia

    by Vinicius Nascimento dos Santos, Eveline Xavier, Maiara Timbó, Ana Gabriela Travassos

    Introduction Post-Exposure Prophylaxis (PEP) is the use of antiretroviral treatment (ART) to reduce the risk of HIV infection after exposure. Interventions based on ART are recommended mostly for key populations, such as people aged 15 to 24 years. This study aims to evaluate the knowledge regarding PEP amongst young university students. Methods Cross section study carried out from August to September 2016 among Health, Education and Exact Sciences students at the State University of Bahia. Socio-epidemiological data regarding sexuality and PEP were collected through a standardised self-applied questionnaire. SPSS v20.0 was used for statistical analysis. Results We enrolled 362 students, 85% (305/359) females, mean age of 22.9 (±4.8) years, 83.1% (301/362) self-declared non-white, 90.6% (327/361) single and 43.4% (154/355) had an income ≤2 minimum wages. As for sexual behaviour, 12.1% (19/177) have sexual intercourse with people of the same sex, 22.6% (63/279) have anal sex, 69.2% (193/279) oral sex; 34.9% (96/275) irregular condom use, including 36.2% (81/224) of Health students (p=0.36). As for the PEP, 39.3% (142/361) have heard about it, 73.6% (14/19) of the men who have sex with men had some knowledge (pConclusion The results evoke the challenges regarding the implantation of new strategies for HIV prevention. The limited knowledge regarding intervention and sites that offers PEP evidences barriers to access and prevention of new infections. These findings highlights the need for disseminate knowledge on PEP among young people, thus making it effective as an HIV prevention strategy.

  • Open Access

    Anogenital infection by Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected men and women in Salvador, Brazil

    by Ana Gabriela Travassos, Eveline Xavier-Souza, Eduardo Netto, Eda Vinhaes Dantas, Maiara Timbó, Isabella Nóbrega, Tatiana Haguihara, Júlia Neumayer, Nathalia Lisboa, Maria Angela Soidan, et al.